Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of Benzbromarone on the Pulmonary Circulation
2015-000709-38Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of benzbromarone in pulmonary arterial hypertension (PAH), sponsored by Medical University of Graz. Primary endpoint: change in pulmonary vascular resistance. Started Jul 2015; status: completed.
02
Drugs
benzbromarone
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2015-000709-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000709-38.